Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response

Journal Article · · Am. J. Roentgenol.; (United States)
DOI:https://doi.org/10.2214/ajr.137.1.31· OSTI ID:6299223
Radionuclide bone scans were performed before and during combination chemotherapy in 119 systematically staged patients with small cell carcinoma of the lung. Before therapy, 49 patients (41%) had positive scans. Scan positivity was significantly associated with the presence of metastatic tumor in the bone marrow, positive skeletal radiographs, and elevated serum alkaline phosphatase levels. Nonosseous distant metastases were significantly more likely to be detected as the number of areas of focal abnormalities on bone scan increased. The survival of patients with documented distant metastases in bone and nonosseous sites was significantly inferior to the survival of patients with limited disease, isolated osseous extensive disease, and extensive disease occurring only in nonbony sites. Serial bone scans provide reasonably accurate staging and prognostic information in patients with small cell lung cancer, although they are probably not sufficiently reliable to be used as the sole parameter in therapeutic decision-making.
OSTI ID:
6299223
Journal Information:
Am. J. Roentgenol.; (United States), Journal Name: Am. J. Roentgenol.; (United States) Vol. 137:1; ISSN AJROA
Country of Publication:
United States
Language:
English